Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial

OBJECTIVE: Most individuals with type 2 diabetes also have obesity, and treatment with some diabetes medications, including insulin, can cause further weight gain. No approved chronic weight management medications have been prospectively investigated in individuals with overweight or obesity and ins...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Care
Autors principals: Garvey, W. Timothy, Birkenfeld, Andreas L., Dicker, Dror, Mingrone, Geltrude, Pedersen, Sue D., Satylganova, Altynai, Skovgaard, Dorthe, Sugimoto, Danny, Jensen, Camilla, Mosenzon, Ofri
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2020
Matèries:
Emerging Therapies: Drugs and Regimens
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7171937/
https://ncbi.nlm.nih.gov/pubmed/32139381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-1745
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars